Earnings Preview: Oncolytics Biotech

Oncolytics Biotech ONCY is gearing up to announce its quarterly earnings on Tuesday, 2024-11-12. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Oncolytics Biotech will report an earnings per share (EPS) of $-0.07.

Anticipation surrounds Oncolytics Biotech's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Performance in Previous Earnings

The company's EPS missed by $0.00 in the last quarter, leading to a 0.97% drop in the share price on the following day.

Here's a look at Oncolytics Biotech's past performance and the resulting price change:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -0.07 -0.08 -0.11 -0.100
EPS Actual -0.07 -0.07 -0.04 -0.104
Price Change % -1.0% -6.0% 1.0% -4.0%

eps graph

Market Performance of Oncolytics Biotech's Stock

Shares of Oncolytics Biotech were trading at $1.07 as of November 08. Over the last 52-week period, shares are down 26.03%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Oncolytics Biotech visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!